Impaired CD8+ T cells in term pregnancy decidua with chronic hepatitis B virus infection

Am J Reprod Immunol. 2022 Oct;88(4):e13610. doi: 10.1111/aji.13610. Epub 2022 Aug 21.

Abstract

Problem: Hepatitis B virus (HBV) infection is more likely to develop a state of chronicity in early life, particularly mother-to-child transmission (MTCT) of HBV in the fetus during pregnancy. Till now, little is known about the impact of chronic HBV infection on the immune status of the maternal-fetus interface, and the immune profile of placental lymphocytes in MTCT of HBV is poorly understood.

Method of study: Thirteen term pregnant women with chronic HBV infection (HBV-PW) and thirteen normal pregnant women as healthy control (HC-PW) were enrolled. The profile of placental immune cells and paired peripheral blood were analyzed by flow cytometry and immunohistochemistry.

Results: Compared with HC-PW, the frequency of CD8+ T cells from the term placenta of HBV-PW was significantly reduced. These cells showed decreased expression of activation molecules CD69 and HLA-DR; thus, decidual CD8+ T cells from HBV-PW demonstrated hypofunctional signature as evidenced by significantly reduced production of IFN-γ, as well as compromised ability of degranulation and proliferation.

Conclusions: These findings supported that hypoactivated decidual CD8+ T cells might possess compromised ability in chronically HBV-infected term pregnant women. Our study provides robust evidence for the necessity and importance of antiviral intervention in HBV-PW to prevent MTCT of HBV.

Keywords: CD8+ T cells; decidual tissue; hepatitis B virus; placenta; term pregnancy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / metabolism
  • Antiviral Agents / therapeutic use
  • CD8-Positive T-Lymphocytes
  • Decidua
  • Female
  • Hepatitis B virus / physiology
  • Hepatitis B*
  • Hepatitis B, Chronic*
  • Humans
  • Infectious Disease Transmission, Vertical / prevention & control
  • Placenta
  • Pregnancy

Substances

  • Antiviral Agents